Modified acellularization for successful vascular xenotransplantation

Won-Min Jo, Young Sang Sohn, Young Ho Choi, Jei Kim Hark, Deuk Cho Hyun

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The purpose of this study was to estimate the possibilities of an acellular matrix using a modified acellularization protocol, which circumvents immunological, microbiological, and physiological barriers. We treated porcine subclavian arteries with various reagents to construct acellular grafts. Afterwards, these grafts were interposed in a mongrel dogs' abdominal aorta. Six dogs underwent interposition with fresh porcine grafts (control group), and seven had interposed acellular grafts (acellular group). The control and acellular group dogs were sacrificed at 1, 3, 5 (n=2 in each group) and 12 months (n=1 in acellular group) after the operation. Histopathological examinations were then performed, to assess the degree to which re-endothelialization, inflammation, thrombus formation, and calcification occurred. The entire acellular group, but none of the control group, exhibited re-endothelialization. The degrees to which inflammation, thrombosis, and calcification occurred were found to be lower in the acellular group. We also discovered many smooth muscle cells in the medial layer of the xenograft that had been implanted in the dog sacrificed 12 months after the operation. These results suggest that the construction of xenografts using our modified acellularization protocol may offer acceptable outcomes as a vascular xenograft.

Original languageEnglish
Pages (from-to)262-269
Number of pages8
JournalJournal of Korean Medical Science
Volume22
Issue number2
Publication statusPublished - 2007 Apr 1

Fingerprint

Heterologous Transplantation
Blood Vessels
Heterografts
Dogs
Transplants
Control Groups
Thrombosis
Swine
Inflammation
Subclavian Artery
Abdominal Aorta
Smooth Muscle Myocytes

Keywords

  • Graft rejection
  • Vascular endothelial cell
  • Xenograft

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jo, W-M., Sohn, Y. S., Choi, Y. H., Hark, J. K., & Hyun, D. C. (2007). Modified acellularization for successful vascular xenotransplantation. Journal of Korean Medical Science, 22(2), 262-269.

Modified acellularization for successful vascular xenotransplantation. / Jo, Won-Min; Sohn, Young Sang; Choi, Young Ho; Hark, Jei Kim; Hyun, Deuk Cho.

In: Journal of Korean Medical Science, Vol. 22, No. 2, 01.04.2007, p. 262-269.

Research output: Contribution to journalArticle

Jo, W-M, Sohn, YS, Choi, YH, Hark, JK & Hyun, DC 2007, 'Modified acellularization for successful vascular xenotransplantation', Journal of Korean Medical Science, vol. 22, no. 2, pp. 262-269.
Jo, Won-Min ; Sohn, Young Sang ; Choi, Young Ho ; Hark, Jei Kim ; Hyun, Deuk Cho. / Modified acellularization for successful vascular xenotransplantation. In: Journal of Korean Medical Science. 2007 ; Vol. 22, No. 2. pp. 262-269.
@article{afb34de7f14f4f10aee0817f5208e5a5,
title = "Modified acellularization for successful vascular xenotransplantation",
abstract = "The purpose of this study was to estimate the possibilities of an acellular matrix using a modified acellularization protocol, which circumvents immunological, microbiological, and physiological barriers. We treated porcine subclavian arteries with various reagents to construct acellular grafts. Afterwards, these grafts were interposed in a mongrel dogs' abdominal aorta. Six dogs underwent interposition with fresh porcine grafts (control group), and seven had interposed acellular grafts (acellular group). The control and acellular group dogs were sacrificed at 1, 3, 5 (n=2 in each group) and 12 months (n=1 in acellular group) after the operation. Histopathological examinations were then performed, to assess the degree to which re-endothelialization, inflammation, thrombus formation, and calcification occurred. The entire acellular group, but none of the control group, exhibited re-endothelialization. The degrees to which inflammation, thrombosis, and calcification occurred were found to be lower in the acellular group. We also discovered many smooth muscle cells in the medial layer of the xenograft that had been implanted in the dog sacrificed 12 months after the operation. These results suggest that the construction of xenografts using our modified acellularization protocol may offer acceptable outcomes as a vascular xenograft.",
keywords = "Graft rejection, Vascular endothelial cell, Xenograft",
author = "Won-Min Jo and Sohn, {Young Sang} and Choi, {Young Ho} and Hark, {Jei Kim} and Hyun, {Deuk Cho}",
year = "2007",
month = "4",
day = "1",
language = "English",
volume = "22",
pages = "262--269",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "2",

}

TY - JOUR

T1 - Modified acellularization for successful vascular xenotransplantation

AU - Jo, Won-Min

AU - Sohn, Young Sang

AU - Choi, Young Ho

AU - Hark, Jei Kim

AU - Hyun, Deuk Cho

PY - 2007/4/1

Y1 - 2007/4/1

N2 - The purpose of this study was to estimate the possibilities of an acellular matrix using a modified acellularization protocol, which circumvents immunological, microbiological, and physiological barriers. We treated porcine subclavian arteries with various reagents to construct acellular grafts. Afterwards, these grafts were interposed in a mongrel dogs' abdominal aorta. Six dogs underwent interposition with fresh porcine grafts (control group), and seven had interposed acellular grafts (acellular group). The control and acellular group dogs were sacrificed at 1, 3, 5 (n=2 in each group) and 12 months (n=1 in acellular group) after the operation. Histopathological examinations were then performed, to assess the degree to which re-endothelialization, inflammation, thrombus formation, and calcification occurred. The entire acellular group, but none of the control group, exhibited re-endothelialization. The degrees to which inflammation, thrombosis, and calcification occurred were found to be lower in the acellular group. We also discovered many smooth muscle cells in the medial layer of the xenograft that had been implanted in the dog sacrificed 12 months after the operation. These results suggest that the construction of xenografts using our modified acellularization protocol may offer acceptable outcomes as a vascular xenograft.

AB - The purpose of this study was to estimate the possibilities of an acellular matrix using a modified acellularization protocol, which circumvents immunological, microbiological, and physiological barriers. We treated porcine subclavian arteries with various reagents to construct acellular grafts. Afterwards, these grafts were interposed in a mongrel dogs' abdominal aorta. Six dogs underwent interposition with fresh porcine grafts (control group), and seven had interposed acellular grafts (acellular group). The control and acellular group dogs were sacrificed at 1, 3, 5 (n=2 in each group) and 12 months (n=1 in acellular group) after the operation. Histopathological examinations were then performed, to assess the degree to which re-endothelialization, inflammation, thrombus formation, and calcification occurred. The entire acellular group, but none of the control group, exhibited re-endothelialization. The degrees to which inflammation, thrombosis, and calcification occurred were found to be lower in the acellular group. We also discovered many smooth muscle cells in the medial layer of the xenograft that had been implanted in the dog sacrificed 12 months after the operation. These results suggest that the construction of xenografts using our modified acellularization protocol may offer acceptable outcomes as a vascular xenograft.

KW - Graft rejection

KW - Vascular endothelial cell

KW - Xenograft

UR - http://www.scopus.com/inward/record.url?scp=34248520621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248520621&partnerID=8YFLogxK

M3 - Article

C2 - 17449935

AN - SCOPUS:34248520621

VL - 22

SP - 262

EP - 269

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 2

ER -